Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Diabetes in Cushing Disease.

G Mazziotti1, A M Formenti2, S Frara3

  • 1Endocrinology Unit, ASST Carlo Poma, Mantova, Italy.

Current Diabetes Reports
|April 2, 2017
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

X-Linked Hypophosphatemia: Role of Fibroblast Growth Factor 23 on Human Skeletal Muscle-Derived Cells.

Calcified tissue international·2025
Same author

Pathophysiology and evaluation of bone health in adrenal diseases.

Endocrine·2025
Same author

Consensus and controversies about diagnosing GH deficiency: a Delphi survey by the GH research society.

Pituitary·2025
Same author

Diabetic Ketoacidosis: Considerations and Residual Controversies in Management After the 2024 ADA, EASD, JBDS, AACE, and DST Joint Consensus.

Endocrine, metabolic & immune disorders drug targets·2025
Same author

Hypophosphatemic rickets in an Italian multicentric cohort of 24 subjects: a clinical and molecular characterisation.

Endocrine·2025
Same author

Medical management pathways for Cushing's disease in pituitary tumors centers of excellence (PTCOEs).

Pituitary·2025

Diabetes mellitus is a common complication of Cushing disease (CD). Management requires addressing hyperglycemia long-term, as it may persist even after cortisol levels normalize, impacting treatment decisions.

Area of Science:

  • Endocrinology
  • Metabolic Disorders
  • Clinical Medicine

Background:

  • Diabetes mellitus is a frequent and early complication of Cushing disease (CD).
  • Glucocorticoid excess in CD causes insulin resistance and impaired insulin secretion, leading to hyperglycemia.
  • Managing diabetes in CD patients presents unique diagnostic and therapeutic challenges.

Purpose of the Study:

  • To review the pathophysiological and clinical aspects of diabetes mellitus in Cushing disease.
  • To highlight the diagnostic, prognostic, and therapeutic implications of this comorbidity.
  • To discuss the impact of diabetes on CD management and vice versa.

Main Methods:

  • Literature review focusing on pathophysiology, clinical presentation, and management strategies.
Keywords:
Cushing diseaseDiabetes:Somatostatin analogshypoglycemic drugs

Related Experiment Videos

  • Analysis of diagnostic challenges and therapeutic considerations in coexisting diabetes and CD.
  • Evaluation of the influence of emerging CD treatments on glucose homeostasis.

    • Main Results:

    • Glucocorticoid-induced diabetes pathogenesis involves both insulin resistance and secretion defects.
    • Hyperglycemia often requires long-term management, as it may persist post-cortisol normalization.
    • Emerging CD therapies, like pasireotide, can independently affect glucose metabolism.
    • Diabetes diagnosis and management in CD can be complicated by cortisol excess markers and treatment interactions.

    Conclusions:

    • Diabetes mellitus is a critical complication of Cushing disease with significant clinical impact.
    • Effective management necessitates a dedicated approach to hyperglycemia, considering its persistence and interaction with CD treatments.
    • Careful consideration of glucose homeostasis is essential when selecting therapies for Cushing disease.